HOME >> BIOLOGY >> NEWS
Faster coagulation rates found in natural systems could impact industrial processing

es found that the beads and the bacterial aggregates collided up to a million times more frequently than predicted using the standard "ideal" particle approach.

The Penn State engineer explains that the fact that large aggregates of bacteria and plankton form in the ocean and sink to the sea floor had long been known even though the prevailing theory could not account for the phenomenon. The settling of organic carbon on the ocean floor, in the form of plankton, bacteria and other biological material, is dominated by large aggregate sedimentation. This loss of organic carbon, which is made possible by coagulation, is an important component of maintaining the global atmospheric carbon dioxide balance.

Now, using the new approach developed by Logan, researchers not only can better understand the ocean processes but also can apply the new approach to enhancing coagulation and aggregation in industrial manufacturing or wastewater treatment.

In addition, in studying the ocean processes, Logan has identified a new particle he calls TEP, transparent exopolymer particles. TEP is formed of material made by plankton that helps it to stick together and coagulate. Logan described TEP in a 1993 paper, "The Abundance and Significance of a Class of Large, Transparent Organic Particles in the Ocean," in the journal Deep-Sea Research.


'"/>

Contact: Barbara Hale
bah@psu.edu
814-865-9481
Penn State
19-Aug-2000


Page: 1 2

Related biology news :

1. Faster carbon turnover in basal food-chain levels in aquatic than terrestrial ecosystems
2. Faster method for growing adult stem cells for bone regeneration developed at Hebrew University
3. Faster nanowires may advance nanotechnological applications for detecting glucose, hormones or DNA
4. Dismantling Dangerous Genetic Codes With A Faster, More Flexible RNA Mimic
5. Scientists Invent Faster Gene Function Identification System
6. Core Spins Faster Than Earth, Scientists Find
7. Intake Of Acetaminophen Increases Risk Of Excessive Anticoagulation In Patients Taking Warfarin
8. ICTP celebrates 40th anniversary, Legacy for the Future
9. New genetic research demonstrates possible cause of inherited form of Parkinsons disease
10. UNC research accelerates discovery of novel gene function
11. Land Regeneration Network celebrates first year success

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2017)... , March 20, 2017 PMD Healthcare ... personal spirometer and Wellness Management System (WMS), a remote, ... Founded in 2010, PMD Healthcare is a Medical Device, ... a mission dedicated to creating innovative solutions that empower ... With that intent focus, PMD developed the first ever ...
(Date:3/9/2017)... SAN FRANCISCO and MOUNTAIN VIEW, ... Zipongo , "Eating Well Made Simple," and 23andMe ... to help guide better food choices.  Zipongo can now ... only their food preferences, health goals and biometrics, but ... to certain food choices. Zipongo,s personalized food ...
(Date:3/2/2017)... 2017 Summary This report provides all ... partnering interests and activities since 2010. ... Read the full report: ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... -- According to a report by Transparency Market Research ... to the presence of a large pool of participants; however, only ... and Sigma-Aldrich, compete with each other in this market. With Proliant ... 76% of this market in 2016.  ... As of now, a large number of vendors ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice ... applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned ...
(Date:3/22/2017)...  Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... address significant unmet medical needs in rare diseases, ... ended December 31, 2016. "2016 ... we broadened our pipeline and pursued our vision ... with an initial focus on endocrinology," said ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
Breaking Biology Technology:
Cached News: